Form 4: Ventas Inc. Executive Peter J. Bulgarelli Sells Shares Under 10b5-1 Trading Plan

Peter J. Bulgarelli, EVP OM&R-Ventas/Pres&CEO-LHS, sold a total of 7,500 shares of Ventas, Inc. common stock on August 26 and 27, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• Peter J. Bulgarelli, an executive at Ventas, Inc., sold shares of the company's common stock.
• The sales occurred on August 26 and August 27, 2024.
• A total of 375 shares were sold on August 26 at a weighted average price of $60.0113, with individual prices ranging from $59.99 to $60.04.
• On August 27, 7,125 shares were sold at a weighted average price of $60.1558, with individual prices ranging from $60.00 to $60.29.
• The transactions were executed under a Rule 10b5-1 trading plan established on March 11, 2024.
• Following these transactions, Bulgarelli directly owns 96,795 shares of Ventas, Inc. common stock.

Sentiment

Score: 5

Explanation: The document itself is neutral, simply reporting the facts of the stock sales. The use of a 10b5-1 plan suggests the sales were pre-planned and not necessarily indicative of a negative outlook.

Positives

• The sales were conducted under a pre-arranged 10b5-1 trading plan, which is a legal and transparent way for insiders to sell shares.

Risks

• Executive share sales can sometimes be perceived negatively by investors, although the use of a 10b5-1 plan mitigates this concern.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance.

Industry Context

Insider trading activity is always closely watched in the REIT sector, as it can provide insights into management's perspective on the company's valuation and future prospects. However, sales under a 10b5-1 plan are generally viewed as less informative since they are pre-planned.

Comparison to Industry Standards

• It's common for executives at publicly traded REITs like Ventas (VTR), Welltower (WELL), and Healthpeak Properties (PEAK) to utilize 10b5-1 trading plans for selling shares.
• The volume of shares sold by Bulgarelli is relatively small compared to the total outstanding shares of VTR, suggesting it's unlikely to have a significant impact on the stock price.
• Similar transactions are routinely disclosed by executives at comparable companies, and the market typically reacts based on the overall trend of insider activity rather than isolated sales under 10b5-1 plans.

Stakeholder Impact

• The share sales could have a minor impact on shareholders if they interpret the sales negatively, although the use of a 10b5-1 plan should mitigate concerns.
• The impact on employees, customers, suppliers, and creditors is likely to be negligible.

Key Dates